What treatment should we use if drugs fail for oab; and, what really works after drugs?

Neurourology and Urodynamics

Volumn 29, Issue 4, 2010, Pages 658-661

  Bosch, J L H R ^a   Kelleher, C ^b   Van Kerrebroeck, P E V ^c   Schurch, B ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Drug treatment; Neuromodulation; Overactive bladder; Urinary incontinence

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; DESMOPRESSIN; MUSCARINIC RECEPTOR BLOCKING AGENT;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BEHAVIOR THERAPY; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; DRUG EFFICACY; FEEDBACK SYSTEM; HUMAN; LUMBOSACRAL PLEXUS; NERVE STIMULATION; NEUROMODULATION; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; PERSONAL EXPERIENCE; TREATMENT FAILURE;

BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; LUMBOSACRAL PLEXUS; NEUROMUSCULAR AGENTS; TREATMENT FAILURE; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 77953600561     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20906     Document Type: Article

References (0)